PROFUND ADVISORS LLC

Position in ALT — Altimmune, Inc.

CIK 1129919 BETHESDA, MD

Position in ALT

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$317,674

+$56,679 QoQ

Shares Held

103,141

+42.7% QoQ

Ownership

0.053%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PROFUND ADVISORS LLC holds $183,565,563 across 158 Biotechnology names. ALT ranks #124 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,137	$10,331,595
2	REGN	Regeneron Pharmaceuticals, Inc.	10,332	$7,982,916
3	ALNY	Alnylam Pharmaceuticals, Inc.	14,647	$4,846,252
4	INSM	INSMED Inc	27,937	$4,568,258
5	APLS	Apellis Pharmaceuticals, Inc.	81,190	$3,266,273
6	MDGL	Madrigal Pharmaceuticals, Inc.	4,862	$2,545,111
7	TGTX	Tg Therapeutics, Inc.	76,039	$2,526,015
8	ARWR	Arrowhead Pharmaceuticals, Inc.	39,758	$2,492,826

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$317,674	103,141	+42.7%	Shares	Sole	2026-04-27
2025-12-31	$260,995	72,298	+114.5%	Shares	Sole	2026-02-06
2025-09-30	$127,094	33,712	+55.3%	Shares	Sole	2025-11-06
2025-06-30	$84,029	21,713	-27.0%	Shares	Sole	2025-08-07
2025-03-31	$148,795	29,759	-2.6%	Shares	Sole	2025-05-08
2024-12-31	$220,265	30,550	-1.3%	Shares	Sole	2025-02-14
2024-09-30	$190,057	30,954	-24.1%	Shares	Sole	2024-11-14
2024-06-30	$271,060	40,761	-69.8%	Shares	Sole	2024-08-13
2024-03-31	$1,372,691	134,842	+43.6%	Shares	Sole	2024-05-08
2023-03-31	$396,338	93,919	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.